Psoriasis
|
Psoriasis is another
one of those conditions that require dietary changes as
well. But even then, it is difficult to get rid of because –
again - because the body is stuck in a chronic cycle of
inflammation. Psoriasis is another one of those conditions that have high amount of the pro-inflammatory cytokine TNF-alpha (tumor necrosis factor alpha). It is known that TNF alpha is elevated in both the skin patients with psoriasis. We also know that Wobenzym decreases TNF-alpha levels. So, it should come as no surprise, when we learn that when Wobenzym is used, there is a marked improvement of clinical symptoms and as well as laboratory values in patients with psoriasis. From FREQUENTLY ASKED QUESTIONS, with answers by Joseph J Collins, RN, ND Read the special section: SKIN CONDITIONS & WOBENZYM® |
What the literature says about Systemic Enzyme Support and:
Wobenzym in the treatment of patients with psoriasis.
Milus I.E. Wobenzym in the treatment of patients with psoriasis.
Zurnal dermatologii i venerologii 1998, 2 (6), 35-36. [Ukrainian]
58
patients (37 women, 21 men), aged 2-58 years, suffering from various
forms of psoriasis were observed. All patients underwent complex,
clinico-laboratory examination.
·
Control - 15 patients, received a conventional therapy (vitamins,
biostimulators, immunocorrectors, fyziotherapy, and softening
ointments).
·
Complex treatment including Wobenzym (3 tablets 3 times a day for 30
days) - 16 patients
·
Complex therapy including external application of Wobe Mugos
ointment - 6 patients
·
Complex therapy including both Wobenzym and Wobe Mugos - 21 patients
Treatment was well tolerated by all patients. In patients in groups
2 and 4, receiving Wobenzym, a significant decrease of exsudative
component of exacerbation was observed after 3-5 days of treatment.
Resting stage of the disease occurred in group 1 after 7-9 days of
treatment, in patients in groups 2 and 4 after 3-5 days. Complete
regression was achieved in group 1 after 28-32 days of treatment, in
group 2 after 24-26 days, in group 3 after 26-28 days, and in group
4 after 18-20 days. Dynamics as well as the exacerbation regression
were accompanied by a marked tendency to the normalization of
biochemical, immunological parameters (most significant in groups 2
and 4).
Results obtained within one year proved a high efficacy of
polyenzyme preparations in the complex treatment of psoriasis.
Disease recurrence within 6-12 months was diagnosed in 6 out of 15
patients in group 1, while only in 7 out of 37 patients in enzyme
treated groups 2 and 4.
Systemic enzyme therapy in dermatology and venerology: perspectives
of its use.
Protsenko T.V. Systemic enzyme therapy in
dermatology and venerology: perspectives of its use. Zurnal
dermatologii i venerologii 1998, 2(6), c.12-13.
255
patients (36 – chlamydiosis, 46 –lues, 43 – psoriasis, 48 –
sclerodermia, 35 – various forms of alopecia, 25 – granuloma anulare,
22 – lipoid necrobiosis) were observed for more than 2 years.
Especially important was a complex treatment of chlamydiosis and
lues patients combined with Wobenzym. Patients received Wobenzym 5-3
dragees 3 times a day in combination with conventional antibacterial
therapy. SET enhanced significantly therapy efficacy, in some cases
even enabled to omit conventional drugs.
Patients suffering from dermatological diseases received Wobenzym
(9-15 dragees daily for at least 4 weeks) and Wobe-Mugos ointment
locally. A marked improvement of clinical symptoms and laboratory
parameters was seen in 61.5% patients, improvement in 19.8%.
No side-effects were reported in all 255 patients.